In this study, an attempt was made to elucidate the combined effect of thymol analogues with propolis on fungi that are involved in human diseases. Antifungal activity of thymol analogues was examined by the agar dilution method, using antibiotic medium-3-enriched with 0.2% dextrose. The activity of thymol analogues against Penicillium rastrickii appeared to be more marked than against Candida albicans and Saccharomyces cerevisiae. Various thymol analogues and propolis, when tested alone, did not exhibit significant inhibitory activity. However, in the presence of sub-inhibitory concentrations of propolis, the relative antifungal potency of the thymol analogues was greatly enhanced. Natural thymol was found to be superior to the synthetic thymol analogues. In particular, the MIC of thymol was considerably reduced (191-fold) against Candida albicans by combination with propolis. This study highlights the potential of the combination of either thymol or synthetic thymol analogues with propolis to inhibit fungi.
Thymol (2-isopropyl-5-methylphenol) is a phenolic monoterpene that is the major component of the essential oil of Thymus vulgaris (Lamiaceae), with potent and broad biological activities, including antimicrobial [1, 2] and antioxidant [3] , and stimulatory actions on Ca 2+ -activated K + currents in pituitary GH3 cells [4] . Natural products have recently been investigated more thoroughly as promising agents for the prevention of oral diseases, especially plaque-related conditions, such as dental caries [5] . Thymol analogues have attracted the attention of scientists in the search for new compounds of either natural or synthetic origin that are active against fungi [6] . Mannich bases of phenolic compounds are often accompanied by antimicrobial activity [7, 8] . In this study, we report the activity of Mannich bases of thymol, synthesized in our laboratory, against fungi [3] .
Invasive fungal infection is associated with significant morbidity and mortality among immunocompromised patients [9] . Combination antifungal therapy has been an area of research and clinical interest. In vitro and clinical data have been generated for some of the more common invasive fungal infections, especially candidasis [10] . A recently completed clinical trial on candidaemia suggested a trend towards improved outcomes among patients receiving amphotericine B combined with fluconazole, as opposed to fluconazole alone [10] .
Propolis (bee glue), a valuable byproduct of apiculture, found in honeybee hives, has been suggested to possess antifungal activities [11, 12] . This encouraged us to study the antifungal activity of some thymol analogues individually, and in combination with propolis, against Candida albicans (ATCC 36232), Saccharomyces cerevisiae (ATCC 2366), and Penicillium rastrickii (ATCC 10490), which are involved in meat spoilage, and certain animal and human diseases [13, 14] . The minimum inhibitory concentration (MIC) for propolis, thymol and its analogues against such fungal species varied depending on the tested compound and the sensitivity of the target strain of fungus. The thymol analogues individually exhibited no significant activity against fungi (143->500.0 μg/mL), as opposed to thymol Although, the various thymol analogues and propolis, when tested alone, did not exhibit any significant inhibitory activity, in the presence of sub-inhibitory concentrations of propolis, the relative antifungal potency of the thymol analogues was greatly enhanced. The MIC for THMO and thymol against S. cerevisiae was reduced from 250.0 to 125.0 μg/mL (2-fold) and from 62.5 to 15.6 μg/mL (4-fold), respectively, in the presence of a sub-inhibitory concentration of propolis (416.7 μg/mL). In particular, the MIC for THMO, THPY and thymol against C. albicans was significantly reduced up to 24-(from 187.5 to 7.8 μg /mL), 37-(from >500 to 13.4 μg/mL) and 191-(from 93.4 to 0.49 μg/mL) fold, respectively, in the presence of a sub-inhibitory concentration of propolis (113.6 μg/mL).The MIC for thymol against P. rastrickii was reduced two-fold (from 125.0 to 62.5 μg/mL) in the presence of propolis (37.9 μg/mL), when compared with the corresponding value for thymol alone. From the above results, it appears that propolis exhibits either a synergistic or potentiating effect upon antifungal activity for the thymol analogues, and that thymol demonstrated the best synergistic efficacy compared with its analogues.
Some mechanisms for the activity of thymol and propolis on organisms have been reported. Research on the antimicrobial action of phenolic compounds has focused on their effects on cellular membranes. The antimicrobial activity of thymol is due to damage to membrane integrity, which further affects pH, homestasis and equilibrium of inorganic ions [15, 16] .
The hypothesized impairment of membranes by thymol are reflected mainly in the dissipation of the two components of the proton motive force, the pH gradient and the electrical potential [15, 16] . Bennis et al. [17] revealed that thymol damaged both the cell membrane and cell wall of yeasts. Conner et al. [18] demonstrated that most essential oils impair the respiratory activity of S. cerevisiae. Propolis damage to C. albicans involves cytocidal activity and an inhibitory effect on yeast-mycelial conversion [19] .
Propolis is a natural remedy that has been employed extensively since ancient times. Modern herbalists recommend it for its antimicrobial, hepatoprotective and anti-inflammatory properties. Up to now, more than 180 compounds, mainly polyphenols, have been identified as constituents of propolis. The major polyphenols are flavonoids, accompanied by phenolic acids and esters, aldehydes and ketones. Other compounds in propolis are volatile oils and aromatic acids, waxes, resins and pollen grains, which are a rich source of essential elements, such as magnesium, nickel, iron and zinc. The main antimicrobial active compounds in propolis are flavonoids, such as pinocembrin, galangin, and pinobanksin [20] . The mechanism of antimicrobial action of propolis seems to be complex. According to Amoros et al. [21] , propolis activity against microorganisms is more related to the effect of the flavonoids rather than to any individual compound. The relative synergism observed with the tested compounds in the presence of propolis might be attributed to the combined targeting of the cytoplasmic membrane since it would appear that both thymol and propolis act upon this structure of fungi as their primary target site.
It was reported that complication of postoperative wound healing either delays or limits the implementation of rehabilitation therapy [22] . C. albicans and Staphylococcus aureus play a pathogenic factor in wound healing in patients after orthopaedic surgery [22] and so the shown antifungal potential of thymol analogues in combination with propolis is of potential medical interest. Our findings point to the potential for the effective application of thymol and its analogues as novel antifungal agents. This is particularly the case when in combination with propolis.
Experimental
Thymol was purchased from Sigma Aldrich (St. Louis, MO, USA). Synthesis and identification of the thymol analogues: THMO (4-morpholinomethyl-2-isopropyl-5-methylphenol), THPY (4-pyrrolidinomethyl-2-isopropyl-5-methylphenol), and THPI (4-piperidinomethyl-2-isopropyl-5-methylphenol) have been reported previously [3] [4] . Propolis was purchased from Eternity Pry Ltd (NSW, Australia).
Antifungal activity of thymol analogues with propolis [24] . For P. rastrickii, the mycelial growth was broken with sterile glass beads. Using a spectrophotometer with an incident wavelength set at 530 nm, the inoculate suspension was adjusted to a level of 90% transmission, which corresponded to approximately 10 6 CFU/mL [24] . Compoundcontaining medium was prepared by adding one volume of diluted thymol analogue solution (in 50% dimethyl sulfoxide) to 9 volumes of autoclaved antibiotic medium-3 agar enriched with 0.2% dextrose that had been cooled to 50 o C, mixed thoroughly and poured into a sterile plate. Agar plates containing thymol analogues and control without them were spotted with a Steer Replicator [25] within 30 min after preparation of the inoculate suspension, as described above. Each spot contained about 1-2 µL of inoculum. The agar plates were allowed to stand until the inoculate spots were completely absorbed into the medium, and then incubated aerobically at 30 o C for 48 h. Compounds were incorporated into agar in serial two-fold concentration from 0.12 to 1000 μg/mL. The MIC was defined as the lowest concentration of compound at which no visible growth of organism was observed.
The antifungal activity test for propolis was conducted in the same manner as that for the thymol analogues, except that the propolis preparation was diluted with 50% ethanol. To evaluate the antifungal effect of propolis combined with thymol analogues, a sub-inhibitory concentration of propolis was mixed with serial, two-fold dilutions of thymol analogues, starting from the respective MIC. If either a four-fold or greater, reduction to the MIC of the compound in the presence of a sub-inhibitory concentration of propolis arose, such an outcome could be defined as synergism. If MIC reduction was two-fold, then the activity of the combination is considered as potentiation [26] .
